DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BACTRIM DS

« Back to Dashboard

Clinical Trials for Bactrim Ds

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000936	A Study To Test An Anti-Rejection Therapy After Kidney Transplantation	Terminated	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3	Kidney transplantation is often successful. However, despite aggressive anti-rejection drug therapy, some patients will reject their new kidney. This study is designed to test two anti-rejection approaches. Two medications in this study are currently used in children, but there is no information regarding which drug is safer or more effective. Survival rates in renal transplantation are unacceptably low. Therefore, there is a need for an improved post-transplant treatment, such as the induction therapy used in this study.
NCT00002524	Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma	Completed	National Cancer Institute (NCI)	Phase 2	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with AIDS-related lymphoma.
NCT00002524	Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma	Completed	M.D. Anderson Cancer Center	Phase 2	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with AIDS-related lymphoma.
NCT00002850	Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy	Completed	Eastern Cooperative Oncology Group	Phase 3	RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients with multiple myeloma and may improve their response to chemotherapy. PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work compared to no antibiotics in preventing early infection in patients with multiple myeloma.
NCT00002850	Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy	Completed	National Cancer Institute (NCI)	Phase 3	RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients with multiple myeloma and may improve their response to chemotherapy. PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work compared to no antibiotics in preventing early infection in patients with multiple myeloma.
NCT00002850	Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy	Completed	Gary Morrow	Phase 3	RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients with multiple myeloma and may improve their response to chemotherapy. PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work compared to no antibiotics in preventing early infection in patients with multiple myeloma.

Clinical Trial Conditions for Bactrim Ds

Condition Name

Condition Name for Bactrim Ds
Intervention	Trials
Abscess	5
Leukemia	5
Urinary Tract Infections	3
Infection	3

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Bactrim Ds
Intervention	Trials
Infection	10
Communicable Diseases	8
Leukemia	7
Abscess	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Bactrim Ds

Trials by Country

Trials by Country for Bactrim Ds
Location	Trials
United States	99
Peru	3
France	3
Kenya	2
Botswana	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Bactrim Ds
Location	Trials
Texas	17
Massachusetts	6
Ohio	6
New York	5
Michigan	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Bactrim Ds

Clinical Trial Phase

Clinical Trial Phase for Bactrim Ds
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	13
Phase 2	15

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Bactrim Ds
Clinical Trial Phase	Trials
Completed	25
Recruiting	12
Terminated	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Bactrim Ds

Sponsor Name

Sponsor Name for Bactrim Ds
Sponsor	Trials
M.D. Anderson Cancer Center	10
National Institute of Allergy and Infectious Diseases (NIAID)	6
National Cancer Institute (NCI)	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Bactrim Ds
Sponsor	Trials
Other	77
Industry	15
NIH	13

Export unavailable in trial.
Subscribe for complete access.